Latest Updates
June 2025
Zlatomics received Angel Investor Funding to accelerate release of Zlatomics' first proprietary product.
December 2024
Engagement with Congress and Senate for initiatives to advance the biotech sector's welfare:
1) Legislation to waive conference fees for laid-off employees. Read more and sign up here to support the initiative!
2) Legislation requiring independent, third-party knowledge assessments prior to leadership promotions in publicly traded biotech/pharma companies.
October 2024
Zlatomics was trending among the top 6% in company prominence on Crunchbase.
Genomics consulting biotechnology consulting DNA gene editing guideRNA crispr screen FLAP Prime editing Gene Editing Genomics NGS Next Generation Sequencing High Throughput Sequencing Leadership Nanopore Sequencing Project Management Mentoring Assay Development Crispr Automation Liquid handler Chemically modified RNA Mammalian Cell Culture Operational Planning Research and Development DNA Extraction RNA extraction Scientific Presentation Interdisciplinary Collaboration Molecular Cellular Biology Bioinformatics Data Analysis Creative Problem Solving Artificial Chromosome Transcription Fellowship Acquisition Grant Writing DNA electrophoresis RNA-Seq GitHub Ubuntu Scientific Publishing Chromatin TT-Seq Strain Engineering Molecular Cloning Scientific Communications MNase-Seq Genome Assembly Python DNA Extraction Epigenetics Data Science Data Modeling Biotechnology Biochemical Molecular Biology Assays Scientific Writing Data Analysis Fluorescence Microscopy Genomics Lentivirus Data Synthesis Bioinformatics RNA Biology Yeast Molecular Genetics Molecular Chaperones Heat shock proteins High Throughput Studies NGS Protein Folding Transcription qRT-PCR qPCR Recombinant Protein Purification PCR DNaseI-Seq Nucleosome Reconstitution Genetics Yeast two-hybrid Column Chromatography Protein Expression DNA Sequencing Mammalian Cell Culture Immunofluorescence ChIP-Seq Western Blotting Epigenetics Proteomics Acetylation Assay Protein Purification E coli In Vitro Transcription EMSA Fluorescence Anisotropy Mass Spectrometry Cancer Research Confocal Microscopy Microarray Analysis Optogenetics Chemistry Bioorganic Chemistry Cellular Biophysics Microbiology Computational Chemistry Precision Medicine DNA Computers RNA synthetic biology genomics consulting services biotechnology consulting services bioinformatics consulting drug discovery consulting genetic engineering consulting precision medicine consulting molecular biology consulting regulatory affairs consulting clinical trials consulting startup consulting venture capital private equity collaboration scientist contract scientist biotechnology innovative research Investors Angel investors Institutional investors